This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.
Wall Street Is Sleeping on This Dividend King Industrial Stock, and That's Your Opportunity There's no question that this high-yield Dividend King is dealing with issues, but the biggest problems are already in the rearview mirror.
The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind Alphabet and Samsung's entry into smart glasses signals a hardware supercycle, challenging Meta's early market lead with EssilorLuxottica.
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter This biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary TYK2 inhibitors.
This SaaS Stock Raised Its 2026 Outlook. A Fund Just Exited a $39 Million Stake This SaaS provider delivers marketing automation and customer data solutions to ecommerce clients across North America and Europe.
Boise Cascade Stock Is Down 23%. One Investor Just Trimmed $27 Million Boise Cascade supplies engineered wood products and building materials to construction markets across the U.S. and Canada.
What to Know About This Fund's $10 Million Bet on Gold Miners ASA Gold and Precious Metals Limited targets global mining equities, specializing in gold, silver, and other precious minerals investments.
What to Know About This Fund's $4 Million Sensient Stock Buy and the Natural Colors Boom Sensient Technologies delivers specialty ingredients and proprietary solutions to global food, beverage, and personal care markets.
SoundHound Stock Sold Off After Record Revenue. Is This AI Stock a Buy? SoundHound's sell-off looks painful, but record growth, LivePerson, and agentic AI could make this one of the market's most interesting high-risk AI stories.
Fluor Is Down 26%. Is It Finally Time to Buy? Infrastructure could be a hot topic for years to come, and this company is responsible for bringing many of those projects to life.
Adams Street Partners Exits Its 223,000-Share Paymentus (PAY) Position for $5.9 Million This cloud-based payments provider delivers SaaS solutions to enterprise billers across utilities, finance, and healthcare sectors.
3 Rare Earth Stocks That Win No Matter What China Does Next A U.S.-China rare earth truce is active through November 2026 — but China is still throttling shipments. Three domestic producers worth watching now.
Where Will Enterprise Products Partners Be in 1 Year? Volatile oil prices make the energy sector exciting, but Enterprise Products Partners is boring.
My Top Energy Stock to Buy Right Now (and It's Not Even Close) Bloom Energy is crushing the market right now, and this stock is not slowing down.
